Topics
What’s in the Retina Pipeline?
SubLiminal Laser for Center-Involving Diabetic Macular Edema
Sponsored by Quantel Medical
View Insert
Retina Pipeline Poster
Business Matters: Maximizing Patient Flow
Editorially independent content supported with advertising by Bausch + Lomb and Regeneron
View Supplement
Epidemiology of Dry AMD and GA
This activity is supported by an unrestricted educational grant from Apellis Pharmaceuticals.
The ACTS Program: Adding Testing to Your Defense Against COVID-19
Sponsored by Avellino
The Surgical Issue
Providing Inflammatory Control in a Patient With Sympathetic Ophthalmia
Sponsored by Bausch + Lomb
Managing Diabetic Macular Edema: Best Practices in Real-World Situations
This activity is supported by an unrestricted educational grant from Allergan.
The Business of Medical Retina: Overcoming Payor Challenges
This activity is supported by supported by an unrestricted educational grant from Regeneron Pharmaceuticals.
What’s Next For nAMD? A Focus On Therapies In The Pipeline
This activity is supported by an unrestricted educational grant from Genentech, a member of the Roche Group.
Diabetic Eye Disease and COVID-19
Business Matters: Avoiding Burnout
Beyond the Anti-VEGFs: An Update on Current and Future AMD Treatment Strategies
COVID-19: Global Retina Responds
Evolutions and Revolutions in Surgical Technology
Sponsored By Alcon
An Exciting Journey in SubLiminal Laser Treatment Therapy for DME
CryoTreq: A New Option For Retinal Cryotherapy
Sponsored by Beaver-Visitec International
The AMD Treatment Burden: Current Status and Promising Solutions
This activity is supported by a grant from Genentech, a member of the Roche Group.
Surviving COVID-19
Business Matters: Surviving the Storm
Choosing the Right Wavelength: Effectiveness of Yellow
Sponsored by LIGHTMED
Diabetic Eye Disease: Expert Discussions on How and When to Treat
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals.
Current and Future Treatments in Age-Related Macular Degeneration: 2019 Year in Review
Photodynamic Therapy in 2020 and Beyond: Current Concepts for Real-World Use
This activity is supported by a grant from Bausch + Lomb.
COVID-19 In Retina
Refining the Use of OCT in Diagnosing Glaucoma
Sponsored by Topcon Healthcare
View Interactive Supplement
Providing Inflammatory Control in a Patient With Relentless Placoid Chorioretinitis
Improved Technology, Speedier Clinics, and Tailored Treatments
Unrestricted Educational Support Provided by ZEISS
Gene Therapy: An Emerging Frontier in the Treatment of Neovascular Diseases
This activity is supported by an independent medical education grant from Adverum Biotechnologies.
Retina Women
Business Matters: Entrepreneurship in Retina
The Role of the New Generation of Lasers in Retina
Insight into Real-World Treatment of nAMD
Techniques and Technologies
Advances in Vitrectomy Probe Technology: The Benefits of Improved Efficiency
Sponsored by Alcon
SS-OCT: Clinical Applications for Diagnosing and Following Ocular Pathology
Navigating the World of Retina: Updates for the Newer Retina Specialist
Supported by unrestricted educational grants from Allergan, Regeneron Pharmaceuticals, and Carl Zeiss Meditec.
Tailoring Therapy to the Neovascular AMD Patient: Implementing Novel Treatment Strategies to Improve Outcomes
Supported by an educational grant from Genentech.
Free Print Subscription
Email Newsletter
Conference Calendar
April 23, 2026
Nanoscope Therapeutics Showcases Vision Restoration Advances at ARVO 2026
Bausch + Lomb Highlights Role of B Vitamins in Reducing AMD Risk in New Scientific Review
OpenAI Launches ChatGPT for Clinicians with New Healthcare-Focused Capabilities
PulseSight Therapeutics to Present First-in-Human PST-611 Trial Results at ARVO
-1_1607102916.jpg?auto=compress,format&w=75)
_1601413920.png?auto=compress,format&w=75)
